Product logins

Find logins to all Clarivate products below.


Transcatheter Embolization and Occlusion Devices | Market Insights | Europe | 2024

The European TEO device market will see modest growth over the forecast period driven by growing adoption of minimally invasive treatment options like embolization. Additionally, the market will be driven by the introduction of new devices, which are being embraced more readily thanks to positive clinical results.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for TEO devices in Europe from 2019 through 2032.

Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Trauma Devices – Market Insights – Europe
Although financial constraints among European healthcare facilities and the rise of GPOs that will exert downward pressure on ASPs will limit the European trauma device market, favorable…
Report
Infusion Pumps – Market Insights – Europe
The European infusion pump demand will be underpinned by aging populations and rising chronic disease, while accelerating adoption of closed-loop, EHR-integrated smart pumps and growing demand of…
Report
Transcatheter Embolization and Occlusion Devices | Market Insights | Latin America (Supplemental) | 2023
Although COVID-19 has negatively impacted the Latin American transcatheter embolization and occlusion device market, the impact of COVID-19 has been limited. The market will expand at a modest rate…
Report
Transcatheter Embolization and Occlusion Devices – Market Insights – Europe
The European TEO device market is projected to experience modest growth over the forecast period, driven by increasing adoption of minimally invasive procedures. The trend is further supported by…